SCHEMBL7530819

SCHEMBL7530819

Cc1ncc(NC(=O)c2cccs2)s1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 12/20 0.62
NPC1 O15118 9/20 0.62
ALDH1A1 P00352 4/20 0.55
SMN1; SMN2 Q16637 6/20 0.54
LMNA P02545 1/20 0.54
PTBP1 P26599 1/20 0.54
HTT P42858 1/20 0.54
KLF5 Q13887 1/20 0.54
PKM P14618 1/20 0.53
KMT2A Q03164 4/20 0.53
MEN1 O00255 2/20 0.53
TDP1 Q9NUW8 1/20 0.53
HPGD P15428 2/20 0.52
TSHR P16473 1/20 0.52
GAPDH P04406 1/20 0.51
TP53 P04637 1/20 0.51
MAPK10 P53779 1/20 0.51
HSD17B10 Q99714 1/20 0.51
ALOX15 P16050 1/20 0.51
KDM4E B2RXH2 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3397250 0.79 RAB9A (0.61) RAB9ANPC1ALDH1A1SMN1; SMN2LMNA
SCHEMBL15737243 0.78 ALDH1A1 (0.57) RAB9ANPC1ALDH1A1SMN1; SMN2LMNA
SCHEMBL1685094 0.77 SMN1; SMN2 (0.59) RAB9ANPC1ALDH1A1SMN1; SMN2LMNA
SCHEMBL10253097 0.77 RAB9A (1.00) RAB9ANPC1ALDH1A1SMN1; SMN2LMNA
SCHEMBL19145052 0.76 ALDH1A1 (0.71) RAB9ANPC1ALDH1A1SMN1; SMN2LMNA
SCHEMBL14394393 0.76 NPC1 (0.69) RAB9ANPC1ALDH1A1SMN1; SMN2LMNA
SCHEMBL19191686 0.74 RAB9A (0.66) RAB9ANPC1ALDH1A1SMN1; SMN2LMNA
SCHEMBL23965986 0.73 L3MBTL1 (0.68) RAB9ANPC1ALDH1A1SMN1; SMN2LMNA
SCHEMBL28033250 0.73 HCAR2 (0.53) SMN1; SMN2PKMTP53HSD17B10ALOX15
SCHEMBL15577212 0.72 ALOX15 (0.52) PKMHSD17B10ALOX15CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002017358-A2 QUINUCLIDINE-SUBSTITUTED HETEROARYL MOIETIES FOR TREATMENT OF DISEASE (NICOTINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS) PHARMACIA & UPJOHN COMPANY (US) 2002-02-28 WO claimed